title: Treatment options for small cell lung cancer - do we have more choice?
abstract: Small cell lung cancer (SCLC) is a significant health problem worldwide because of its high propensity for relapse. This review discusses existing and future therapies for the treatment of SCLC.
authors.affiliation: Department of Medicine, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
authors.forename: M
authors.initials: M
authors.lastname: Puglisi
authors.forename: S
authors.initials: S
authors.lastname: Dolly
authors.forename: A
authors.initials: A
authors.lastname: Faria
authors.forename: J S
authors.initials: JS
authors.lastname: Myerson
authors.forename: S
authors.initials: S
authors.lastname: Popat
authors.forename: M E R
authors.initials: ME
authors.lastname: O'Brien
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D024221:Antineoplastic Protocols; D035843:Biomedical Research / Q000639:trends; D002755:Choice Behavior; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging / Q000379:methods; D011379:Prognosis; D055752:Small Cell Lung Carcinoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents